• PSM Applauds INTERPOL, Industry Partnership to Combat Counterfeit Medicines

    March
    12, 2013 (Washington, D.C.)
    The Partnership for Safe Medicines
    (PSM), the leading advocacy organization dedicated to fighting the spread of
    counterfeit drugs, applauds today’s
    announcement
    of a bold new initiative between INTERPOL
    and the pharmaceutical industry to combat the global health threat of
    counterfeit and fake medicines.

    This new initiative broadens the scope of the
    successful Medical Product Counterfeiting and Pharmaceutical Crime Unit through
    the creation of a Pharmaceutical Crime Program to assist and enhance worldwide
    law enforcement efforts. Thomas Kubic, PSM Board Member and CEO of the
    Pharmaceutical Security Institute, released the following statement hailing the
    new agreement:

    Interpol image

    Image courtesy of INTERPOL.

    March
    12, 2013 (Washington, D.C.)
    The Partnership for Safe Medicines
    (PSM), the leading advocacy organization dedicated to fighting the spread of
    counterfeit drugs, applauds today’s
    announcement
    of a bold new initiative between INTERPOL
    and the pharmaceutical industry to combat the global health threat of
    counterfeit and fake medicines.

    This new initiative broadens the scope of the
    successful Medical Product Counterfeiting and Pharmaceutical Crime Unit through
    the creation of a Pharmaceutical Crime Program to assist and enhance worldwide
    law enforcement efforts. Thomas Kubic, PSM Board Member and CEO of the
    Pharmaceutical Security Institute, released the following statement hailing the
    new agreement:

    “Counterfeit medicines threaten the
    lives of millions of people around the world, and finding ways to address such
    a complex, far-reaching issue requires ever-increasing global cooperation. The
    partnership announced today between INTERPOL and 28 of the world’s largest
    pharmaceutical companies is just the kind of progress we need to help keep
    patients safe from this global health menace.

    “The three-year agreement is a positive
    step forward for anti-counterfeiting efforts, fostering heightened cooperation
    between INTERPOL, the biopharmaceutical industry, and law enforcement agencies
    that goes above and beyond INTERPOL’s ongoing successful activities to combat
    pharmaceutical crime.

    “The sad truth is that patients don’t even
    realize the scope of the problem of counterfeit medicines, as well as the
    lengths that criminals will go to prey upon unsuspecting victims. Efforts like
    this new initiative will go a long way to not only help stop counterfeits from
    reaching their medicine cabinets, but also raise awareness of the dangers of
    fake drugs. Just in the U.S. last year, the FDA warned 370 doctors in 38 states
    that they could have purchased counterfeit medications, and in some countries
    up to 40% of their medicine supply may be counterfeit, which is simply
    unacceptable. PSM applauds INTERPOL and the biopharmaceutical industry on this
    new partnership, and we look forward to seeing the results of their hard work
    on an issue of such global significance.”

    According to INTERPOL, the new program will
    involve training, capacity building and enforcement actions along with efforts
    to raise public awareness, and will include actions to disrupt and dismantle
    organized crime networks engaging in pharmaceutical crime. More information
    about the program can be found at www.interpol.int.

Comments are closed.